EUVIMEDEUVIMED entdecken
Open Access

STK38/L promote tissue growth and cancer by inhibiting the Hippo pathway

Jeongmin An, Zhen Huang, Amrutha Kizhedathu, Tian Lan, Tzuling Lin, Hyejin Joo, Eshan Malinda Thilakaratne, Yuhan Liu, Yun Yi Xu, Bing Yang, Pablo Lara-Gonzalez, Rahul Warrior und 2 weitere

Genes & Development · 01.07.2026 · 40 (13-14) · 1080-1098

DOI: 10.1101/gad.353309.125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Development, online erschienen am 13.05.2026. Verfasst von Jeongmin An und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental and Cell Biology, University of California, Irvine, Irvine, California 92697, USA. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Signal Transduction, Drosophila Proteins, Intracellular Signaling Peptides and Proteins. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Hippo pathway is a key regulator of development, regeneration, tissue homeostasis, and organ size, and its dysregulation promotes tumorigenesis. However, the precise mechanisms of its regulation in both normal physiology and cancer remain incompletely understood. Here, we identify STK38 and STK38L (also known as NDR1 and NDR2), previously proposed as redundant kinases of LATS, as negative regulators of the Hippo pathway. STK38/L inhibit LATS by competitively binding to MOB1 and disrupting the LATS–MOB1 complex, a process independent of their kinase activity. This inhibitory mechanism is evolutionarily conserved, as the Drosophila ortholog Tricornered similarly impairs Warts–Mats complex formation, resulting in enlarged fly wing size. Pathologically, STK38L is highly expressed in ovarian cancer and required for ovarian tumor growth, and its amplification correlates with YAP activation and increased tumor sensitivity to TEAD inhibitors. Taken together, our study reveals a conserved role of STK38/L in Hippo pathway regulation, providing new insights into Hippo-dependent growth control and cancer development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesSignal TransductionDrosophila ProteinsIntracellular Signaling Peptides and ProteinsOvarian NeoplasmsDrosophila melanogasterGene Expression Regulation, NeoplasticAnimalsFemaleHippo KinasesHumansAdaptor Proteins, Signal TransducingHippo Signaling PathwayYAP-Signaling ProteinsWings, AnimalProtein BindingTumor Suppressor Proteins

Stichwörter der Autor:innen

HippoLATS1MOB1STK38STK38LYAPcancer

Substanzen

Protein Serine-Threonine KinasesDrosophila ProteinsHippo Kinaseshpo protein, DrosophilaIntracellular Signaling Peptides and ProteinsSTK38L protein, humanAdaptor Proteins, Signal TransducingMats protein, DrosophilaYAP-Signaling ProteinsSTK38 protein, human

Autor:innen und Institutionen

  • Department of Developmental and Cell Biology, University of California, Irvine, Irvine, California 92697, USA.
  • Chemical and Materials Physics Graduate Program, University of California, Irvine, Irvine, California 92697, USA.
  • Department of Biomedical Engineering, University of California, Irvine, Irvine, California 92697, USA.
  • Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, California 92697, USA.
  • Department of Chemical and Biomolecular Engineering, University of California, Irvine, Irvine, California 92697, USA.
  • Department of Materials Science and Engineering, University of California, Irvine, Irvine, California 92697, USA.

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • National Cacner Institute
  • University of California, Irvine, Chao Family Comprehensive Cancer Center

Zitieren

APA

An, J., Huang, Z., Kizhedathu, A., Lan, T., Lin, T., Joo, H., Thilakaratne, E. M., Liu, Y., Xu, Y. Y., Yang, B., Lara-Gonzalez, P., Warrior, R., Luo, R., & Wang, W. (2026). STK38/L promote tissue growth and cancer by inhibiting the Hippo pathway. Genes & Development, 40(13-14), 1080-1098. https://doi.org/10.1101/gad.353309.125

Vancouver

An J, Huang Z, Kizhedathu A, Lan T, Lin T, Joo H, et al. STK38/L promote tissue growth and cancer by inhibiting the Hippo pathway. Genes & Development. 2026;40(13-14):1080-1098. doi:10.1101/gad.353309.125

BibTeX
@article{An2026,
  author = {An, Jeongmin and Huang, Zhen and Kizhedathu, Amrutha and Lan, Tian and Lin, Tzuling and Joo, Hyejin and Thilakaratne, Eshan Malinda and Liu, Yuhan and Xu, Yun Yi and Yang, Bing and Lara-Gonzalez, Pablo and Warrior, Rahul and Luo, Ray and Wang, Wenqi},
  title = {STK38/L promote tissue growth and cancer by inhibiting the Hippo pathway},
  journal = {Genes & Development},
  year = {2026},
  volume = {40},
  number = {13-14},
  pages = {1080--1098},
  doi = {10.1101/gad.353309.125}
}
Kostenlos starten →